+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA 3D Cell Culture Market Size, Share & Industry Trends Analysis Report by Type (Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinted), Application, End-user, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 93 Pages
  • October 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5694331
The Latin America, Middle East and Africa 3D Cell Culture Market should witness market growth of 19.7% CAGR during the forecast period (2022-2028).

Spheroids are a sort of three-dimensional cell modeling that simulates the environment of a living cell more accurately than two-dimensional cell models, particularly in terms of the interactions between cells and the interactions between cells and the matrix. Spheroids are valuable for studying the changing physiological features of cells, the structural difference between healthy and cancerous cells, and the changes that occur in cells during tumor formation.

Spheroids co-cultured containing tumors along with healthy cells were utilized to imitate the interaction between malignant and healthy cells. Spheroids can also be co-cultured with fibroblasts to simulate the interaction between tumors and stroma. Multiple ways exist for cultivating spheroids. To mass-produce spheroid cultures, it is customary to employ low cell adhesion plates, often a 96-well plate, where the aggregates develop in the curved bottom of the cell plates.

Alternatively, spheroids can be cultivated using the hanging drop technique, which involves the formation of cell aggreahey are in constant free fall and creates aggregates and layers is also under consideration. Recently, standardized techniques for producing consistent and reliable spheroids have been developed. Researchers had also investigated standard, cost-effective, and reproducible 3D cell culture methods.

There are a number of underdeveloped countries in the region, whose governments are strengthening their efforts to bring about fresh growth opportunities. In regional nations, such as South Africa and Brazil, the demand for innovative and more efficient pharmaceutical services and technology is consistently growing. Due to this, numerous researchers are implementing a 3D cell culture approach in order to address the region's expanding demand.

The Brazil market dominated the LAMEA 3D Cell Culture Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $54.8 million by 2028. The Argentina market is experiencing a CAGR of 20.3% during (2022-2028). Additionally, The UAE market would display a CAGR of 19.4% during (2022-2028).

Based on Type, the market is segmented into Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinted. Based on Application, the market is segmented into Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing, and Tissue Engineering & Regenerative Medicine. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Research Institutes, Cosmetic Industry, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Nvidia Corporation, IBM Corporation, Intel Corporation, Google LLC, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Xilinx, Inc., Digital Diagnostics, Inc. and InformAI, LLC.

Scope of the Study

By Type

  • Scaffold-based
  • Scaffold-free
  • Microfluidics-based
  • Magnetic & Bioprinted

By Application

  • Cancer & Stem Cell Research
  • Drug Discovery & Toxicology Testing
  • Tissue Engineering & Regenerative Medicine

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Cosmetic Industry
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • Avantor, Inc.
  • Corning Incorporated
  • Lonza Group AG
  • Mimetas B.V.
  • Insphero AG
  • Emulate, Inc.
  • Tecan Group Ltd.
  • CN Bio Innovations Ltd.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA 3D Cell Culture Market, by Type
1.4.2 LAMEA 3D Cell Culture Market, by Application
1.4.3 LAMEA 3D Cell Culture Market, by End-user
1.4.4 LAMEA 3D Cell Culture Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 The Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, May - 2022, Oct) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun - 2022, Jun) Leading Players
Chapter 4. LAMEA 3D Cell Culture Market by Type
4.1 LAMEA Scaffold-based Market by Country
4.2 LAMEA Scaffold-free Market by Country
4.3 LAMEA Microfluidics-based Market by Country
4.4 LAMEA Magnetic & Bioprinted Market by Country
Chapter 5. LAMEA 3D Cell Culture Market by Application
5.1 LAMEA Cancer & Stem Cell Research Market by Country
5.2 LAMEA Drug Discovery & Toxicology Testing Market by Country
5.3 LAMEA Tissue Engineering & Regenerative Medicine Market by Country
Chapter 6. LAMEA 3D Cell Culture Market by End-user
6.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
6.2 LAMEA Research Institutes Market by Country
6.3 LAMEA Cosmetic Industry Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA 3D Cell Culture Market by Country
7.1 Brazil 3D Cell Culture Market
7.1.1 Brazil 3D Cell Culture Market by Type
7.1.2 Brazil 3D Cell Culture Market by Application
7.1.3 Brazil 3D Cell Culture Market by End-user
7.2 Argentina 3D Cell Culture Market
7.2.1 Argentina 3D Cell Culture Market by Type
7.2.2 Argentina 3D Cell Culture Market by Application
7.2.3 Argentina 3D Cell Culture Market by End-user
7.3 UAE 3D Cell Culture Market
7.3.1 UAE 3D Cell Culture Market by Type
7.3.2 UAE 3D Cell Culture Market by Application
7.3.3 UAE 3D Cell Culture Market by End-user
7.4 Saudi Arabia 3D Cell Culture Market
7.4.1 Saudi Arabia 3D Cell Culture Market by Type
7.4.2 Saudi Arabia 3D Cell Culture Market by Application
7.4.3 Saudi Arabia 3D Cell Culture Market by End-user
7.5 South Africa 3D Cell Culture Market
7.5.1 South Africa 3D Cell Culture Market by Type
7.5.2 South Africa 3D Cell Culture Market by Application
7.5.3 South Africa 3D Cell Culture Market by End-user
7.6 Nigeria 3D Cell Culture Market
7.6.1 Nigeria 3D Cell Culture Market by Type
7.6.2 Nigeria 3D Cell Culture Market by Application
7.6.3 Nigeria 3D Cell Culture Market by End-user
7.7 Rest of LAMEA 3D Cell Culture Market
7.7.1 Rest of LAMEA 3D Cell Culture Market by Type
7.7.2 Rest of LAMEA 3D Cell Culture Market by Application
7.7.3 Rest of LAMEA 3D Cell Culture Market by End-user
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent Strategies and Developments
8.1.5.1 Product Launches and Product Expansions
8.1.5.2 Acquisition and Mergers
8.1.5.3 Geographical Expansions
8.2 Merck Group
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent Strategies and Developments
8.2.5.1 Partnerships, Collaborations, and Agreements
8.3 Avantor, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Recent Strategies and Developments
8.3.4.1 Partnerships, Collaborations, and Agreements
8.3.4.2 Acquisition and Mergers
8.4 Corning Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent Strategies and Developments
8.4.5.1 Product Launches and Product Expansions
8.5 Lonza Group AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent Strategies and Developments
8.5.5.1 Partnerships, Collaborations, and Agreements
8.5.5.2 Geographical Expansions
8.6 Mimetas B.V.
8.6.1 Company Overview
8.6.2 Recent Strategies and Developments
8.6.2.1 Product Launches and Product Expansions
8.7 Insphero AG
8.7.1 Company Overview
8.7.2 Recent Strategies and Developments
8.7.2.1 Partnerships, Collaborations, and Agreements
8.7.2.2 Product Launches and Product Expansions
8.8 Emulate, Inc.
8.8.1 Company Overview
8.9 Tecan Group Ltd.
8.9.1 Company Overview
8.10. CN Bio Innovations Ltd.
8.10.1 Company Overview
8.10.2 Recent Strategies and Developments
8.10.2.1 Partnerships, Collaborations, and Agreements
8.10.2.2 Product Launches and Product Expansions
8.10.2.3 Geographical Expansions

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • Avantor, Inc.
  • Corning Incorporated
  • Lonza Group AG
  • Mimetas B.V.
  • Insphero AG
  • Emulate, Inc.
  • Tecan Group Ltd.
  • CN Bio Innovations Ltd.

Methodology

Loading
LOADING...